Labshake search
Citations for Invivogen :
51 - 100 of 530 citations for 2H Pyrazolo 4 3 c pyridine 3 chloro 4 5 6 7 tetrahydro since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: Immune responses were induced in 6-12-week-old male and female mice by subcutaneous immunization in the right FP with 5 µg (for HA experiments) or 10 µg (for hapten-carrier experiments) supplemented with 1/3 volume alhydrogel adjuvant (Invivogen). In S1pr2-Tomato mice ...
-
bioRxiv - Molecular Biology 2022Quote: ... and 4 μg ml-1 puromycin (InvivoGen), and grown at 37 °C in an atmosphere containing 5% CO2 ...
-
bioRxiv - Immunology 2020Quote: ... for 3 days with 0.5 μg/mL LPS (Invivogen) and 0.5 μg/mL anti-IgM F(ab’)2 (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... (3) LPS and 150 μg/ml Polymyxin B (Invivogen) for 45 and 90 min ...
-
bioRxiv - Immunology 2022Quote: ... which were selected by blasticidin (3 μg/ml, InvivoGen) for 4 days prior to the experiments.
-
bioRxiv - Cell Biology 2024Quote: ... Pam-3-CSK4 (500 ng/mL, InvivoGen; tlrl-pms), PolyI:C (10 mg/mL ...
-
bioRxiv - Molecular Biology 2024Quote: ... 2 days after transfection the cells were transferred to 10 cm dish and 4-5 days after transfection cells were selected with 100 μg/ml Hygromycin (InvivoGen). All CRIS-PITCh plasmids are summarized in Table S1.
-
bioRxiv - Immunology 2022Quote: ... for 3 hr followed by (flagellin isolated from P. aeruginosa, 2 or 5 µg/mL) for 3 hr using FLA-PA Ultrapure (InvivoGen, tlrl-pafla) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2021Quote: ... 4 µg cGAMP (Invivogen, San Diego, Californien, USA), 4 µg c-di-UMP (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... for 4 hours and 10 μM nigericin (InvivoGen) for an additional 1 hour ...
-
bioRxiv - Immunology 2023Quote: ... and assayed with QUANTI-Luc 4 reagent (Invivogen). Luminescence was read immediately with an Envision system.
-
bioRxiv - Immunology 2023Quote: ... selective medium containing Puromycin (4 μg/ml, InvivoGen) was added and after 7 days cells were sorted using FACS Aria (BD ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were exposed to puromycin (3 μM final concentration, Invivogen) for 5 minutes or left untreated for control conditions ...
-
bioRxiv - Microbiology 2024Quote: ... and 3 µg/ml of Puromycin (Invivogen, #ant-pr-1). ACE2 overexpressing MRC5 cells were cultivated in DMEM supplemented with 20% (v/v ...
-
bioRxiv - Immunology 2024Quote: 2’-3-cyclic GMP-AMP (cGAMP) (tlrl-nacga23-1, InvivoGen) was added at 10μg/mL with or without 4μM H151 (inh-h151 ...
-
bioRxiv - Cell Biology 2024Quote: ... Transduced organoids were selected using 3 μg/ml blasticidin (InvivoGen) and maintained as polyclonal populations.
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... Omicron Variant (B.1.1.529/BA.1) pLV-SpikeV11) and Omicron Variants (BA.4/BA.5) pLV-SpikeV13) were purchased from InvivoGen (San Diego, CA). The human T-Cell lymphoma Jurkat (E6-1 ...
-
bioRxiv - Cell Biology 2024Quote: ... Samples were washed 3 times with 5 ml of phosphate-buffered saline (PBS) containing 100 μg/mL Primocin® (Invivogen, ant-pm-05) and 20 μg/mL Gentamicin (Thermo Fisher Scientific ...
-
bioRxiv - Microbiology 2022Quote: ... extraction buffer supplemented with a final concentration of 0.01% formic acid and 25nM c-di-GMP-Fluorinated internal standard (InvivoGen CAT: 1334145-18-4). Pelleted cells were mechanically disturbed with the Qiagen TissueLyser LT at 50 oscillations/second for 2 minutes.
-
bioRxiv - Cell Biology 2021Quote: ... at 37 °C in 5% C02 and maintained in 5 µg.mL-1 Hygromycin (InvivoGen) and 5 µg.mL-1 Phleomycin (InvivoGen).
-
bioRxiv - Immunology 2020Quote: ... and selected with 4 μg mL−1 puromycin (InvivoGen) for two weeks.
-
bioRxiv - Molecular Biology 2021Quote: ... Calu-3 (ACE2) cells further received 0.5 μg/ml puromycin (Invivogen). A549-ACE2 (Hoffmann et al. ...
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... Elution was performed with free 2′3′-cGAMP (100 μM; InvivoGen), 3′3′-cGAMP (100 μM ...
-
bioRxiv - Immunology 2024Quote: ... and 3 μg mL−1 puromycin (InvivoGen, cat. no. ant-pr). Expi293F cells were maintained in Expi293 media in a shaking incubator at 37°C and 8% CO2.
-
bioRxiv - Immunology 2024Quote: ... prior to transfection with 2′3′-cGAMP (10 µg/ml, InvivoGen) using Lipofectamine 2000 (Thermo Fischer Scientific) ...
-
bioRxiv - Developmental Biology 2024Quote: ... The chemical inhibitor or DMSO solution was replaced with fresh solution in the morning of 4 dpf and 5 dpf. Caspase-1 inhibitor - InvitroFit™ Ac-YVAD-cmk (Garcia-Calvo et al. 1998) (InvivoGen inh-yvad) was dissolved in DMSO and used at 20µM final working concentration ...
-
bioRxiv - Immunology 2021Quote: ... was mixed with an Al (OH)3 adjuvant (Alhydrogel®, InvivoGen, France) and used as a candidate vaccine against SARS-CoV-2 ...
-
bioRxiv - Immunology 2020Quote: ... the medium was supplemented with 3 μM puromycin (InvivoGen, #ant-pr-1). Then ...
-
bioRxiv - Cell Biology 2020Quote: ... Stable transformants were selected using 4 μg/mL Blasticidin (Invivogen) and individual colonies were picked ...
-
bioRxiv - Immunology 2021Quote: HEK-Blue™ IL-4/IL-13 cells (InvivoGen, France) were cultured according to manufacturer’s instructions ...
-
bioRxiv - Microbiology 2022Quote: ... the medium was further supplemented with puromycin (7 μg/ml for selection of clones or 6 μg/ml for maintenance of cell lines; Invivogen) and/or hygromycin (100 μg/ml for selection of clones or 70 μg/ml for maintenance of clones ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were treated with 3 μg/ml plasmocin (Invivogen, San Diego, CA, USA) to prevent mycoplasma contamination ...
-
Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistancebioRxiv - Cancer Biology 2024Quote: ... Infected cells were selected using puromycin for 3 days (2 µg/ml, InvivoGen) or hygromycin B for 7 days (500 µg/ml ...
-
bioRxiv - Immunology 2022Quote: ... and with 3 μg/ml TLR7 agonist imiquimod (InvivoGen, San Diego, CA, USA) for 3 days ...
-
bioRxiv - Immunology 2024Quote: ... and caspase-1/4 inhibitor VX-765 (Invivogen, inh-vx765i-1) while on ice ...
-
bioRxiv - Immunology 2022Quote: ... Cells were washed and cultured for 5-7 days in the presence of puromycin (2 µg/ml, InvivoGen). Selected cells were expanded ...
-
bioRxiv - Cell Biology 2021Quote: ... infected cells were selected with medium containing 3 μg/ml puromycin medium (Invivogen, CA) for 4 days and resulting heterogenous pools were used for functional assays ...
-
bioRxiv - Immunology 2021Quote: ... and incubated for 3 hours in the presence of LPS (10 ng/ml, Invivogen). Primary monocytes were then treated for 1 h 30 with nigericin (5 μM ...
-
bioRxiv - Biophysics 2023Quote: ... MEFs stably expressing Skylan-NS–LC3B were selected with 3 µg/mL puromycin (Invivogen), seeded on a glass slide coated with 0.3 mg/ml collagen (Nitta Gelatin ...
-
bioRxiv - Biophysics 2023Quote: ... Cell culture media was supplemented with 3 µg/ml puromycin (InvivoGen, San Diego, USA). As a control ...
-
bioRxiv - Immunology 2023Quote: ... cells were transferred to selective medium containing 4 µg/mL Blasticidin (Invivogen) (MC38-B2m-/- transduced with Her2/neu ...
-
bioRxiv - Systems Biology 2023Quote: ... TLR4 agonist at 4 ng/mL (LPS-B5, Invivogen, San Diego, CA), BTC at 40 ng/mL (human recombinant Betacellulin protein ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated with 12.5 or 25 μg/mL 2’-3’cGAMP (Invivogen tlrl-nacga23) for 2 hr as indicated ...
-
bioRxiv - Immunology 2024Quote: ... BMDCs were pretreated for 3 hours with either TLR4 inhibitor TAK-242 (InvivoGen, #tlr-cli95) at three different concentrations (1.25 μM ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 10 mg/kg anti-CTLA-4 (clone 9D9, cat. mctla4-mab10, InvivoGen). Antibodies were administered twice weekly for a maximum of four weeks.
-
bioRxiv - Immunology 2024Quote: ... all cells were centrifuged for 5 minutes at 300 x g and the medium was replaced with myeloid medium containing 7 µg/mL puromycin (Invivogen) to select cells transduced for 72 hours.
-
bioRxiv - Biochemistry 2024Quote: ... HeLa cells were then cultured under selection with 3 μg/mL puromycin (InvivoGen, ant-pr-1) for 48hr and then expanded before storing stocks in liquid nitrogen.
-
bioRxiv - Cell Biology 2023Quote: ... cells were selected in culture medium supplemented with 3 µg/ml puromycin (Invivogen, ant-pr-1), and selection was completed for 48 h before cells were harvested ...
-
bioRxiv - Immunology 2023Quote: ... and absorbance levels detected at 655 nm after 3 h incubation with QUANTI-Blue Solution (Invivogen). The absorbances of RAW-Blue assay were normalized to absorbance intensity at the highest and lowest dilutions ...
-
bioRxiv - Immunology 2020Quote: ... the cells were primed for 4 h with 500 ng/mL ultrapure LPS (InvivoGen). The supernatant was discharged and macrophages were infected with trypomastigote forms of T ...